MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-TS-09-0015667
Ikem Pharma Private Limited
Ikem Pharma Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹6.87 Cr
▼ 62% YoY
Net profit · FY 2024
₹9.39 Lakh
Net margin 1.4%
EBITDA · FY 2024
₹38.06 Lakh
EBITDA margin 5.5%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Open charges
₹50 Lakh
Secured borrowings
Company age
6 yrs
Est. 2020
Directors on board
3
As per MCA filings
About Ikem Pharma Private Limited
Data last updated:
Ikem Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 07 September 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24290TG2020PTC143617. Its GSTIN is 36AAFCI7909A1ZQ (Telangana).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Nagireddy Sanapalli and Sanapalli Subbareddy.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2024, the company reported a revenue of ₹6.87 Cr, a decline of 62% compared to the previous year. For the same year it recorded a net profit of ₹9.39 Lakh (net margin 1.4%) and EBITDA of ₹38.06 Lakh (EBITDA margin 5.5%). Revenue has grown at a compounded annual rate (CAGR) of 18% over three years.
As per MCA filings, the company has open charges of ₹50 Lakh on record.
Ikem Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-09-0015667).
Company details
CIN U24290TG2020PTC143617
Registration Number 143617
Incorporation Date 07 September 2020
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-TS-09-0015667
Recognitions & Rankings of Ikem Pharma
Contact details
Ikem Pharma Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address5 – 5 – 35/33/1 Ncs Complex, 2nd Floor Prasanthi Nagar, Hyderabad, Telangana, India – 500072
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Ikem Pharma Private Limited, buy the company report.
Comprehensive company report
Ikem Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Ikem Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Ikem Pharma Private Limited, buy the company report.
Financials of Ikem Pharma Private Limited
FY 2025 filings availableIkem Pharma Private Limited reported revenue of ₹6.87 Cr (down 62% YoY) for FY 2024.
Revenue · FY 2024
₹6.87 Cr ▼ 62%
Net profit · FY 2024
₹9.39 Lakh margin 1.4%
EBITDA · FY 2024
₹38.06 Lakh margin 5.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 62%
3 years · compounded
▲ 18%
EBITDA CAGR growth
1 year
▲ 1%
3 years · compounded
▲ 49%
Revenue fell 62% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 18%. EBITDA rose 1% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹38.06 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹9.39 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 5.5% | |||
| Net Profit Margin | 1.4% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Ikem Pharma Private Limited, buy the company report.
Board of directors of Ikem Pharma Private Limited
Ikem Pharma has 3 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nagireddy Sanapalli Also directs: SNR Drugs Private Limited, Kshiti Pharma Private Limited | Director | 07 Sep 2020 | 6 Years 1 Months | Current |
| Sanapalli Subbareddy Also directs: SNR Drugs Private Limited, Kshiti Pharma Private Limited | Director | 07 Sep 2020 | 6 Years 1 Months | Current |
| Swapna Mukkara | Director | 07 Sep 2020 | 6 Years 1 Months | Current |
Peer comparison
Ikem Pharma Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Vikram Laboratories Private Limited | ₹6.9 Cr (FY 2025) | -25.0% | Uttar Pradesh, India | |||
| Vivifi Life Sciences Private Limited | ₹6.89 Cr (FY 2024) | 9.0% | Thiruvananthapuram, Kerala, India | |||
| Ikem Pharma Private Limitedthis company | ₹6.87 Cr (FY 2024) | ₹9.39 Lakh | 1.4% | -62.0% | Hyderabad, Telangana, India | |
| Good Kare Medico Private Limited | ₹6.86 Cr (FY 2025) | 4.0% | Saharanpur, Uttar Pradesh, India | |||
| Daiwik Pharmasphere Private Limited | ₹6.85 Cr (FY 2023) | 82.0% | Navsari, Gujarat, India | |||
| Colinz Laboratories Ltd | ₹6.83 Cr (FY 2025) | -7.0% | Mumbai, Maharashtra, India | |||
| Beid Healthcare Private Limited | ₹6.81 Cr (FY 2024) | -77.0% | Navi Mumbai, Maharashtra, India |
To see the full peer comparison of Ikem Pharma Private Limited, buy the company report.
Auditor
Ikem Pharma Private Limited is audited by RAMIREDDY H R N V VISWANATH & Associates for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAMIREDDY H R N V VISWANATH & Associates | FY 2021 |
Shareholding
The shareholding of Ikem Pharma Private Limited is on record for FY 2021, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2021 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Ikem Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹50 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 29 May 2023 | 100769359 | Axis Bank Limited | ₹50 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Ikem Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ikem Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Ikem Pharma Private Limited has 1 active EPFO establishment as of Apr 09, 2024.
Active EPFO establishments
1
GST
Ikem Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAFCI7909A1ZQ | Telangana | Active | 12 Sep 2020 |
To see the full GST registrations and return filing status of Ikem Pharma Private Limited, buy the company report.
Recent activity
Ikem Pharma Private Limited has 3 board changes on record since 2020: 3 appointments. The latest: Nagireddy Sanapalli was appointed as Director on 07 Sep 2020.
AGM
Ikem Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Ikem Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Charges
A charge with Axis Bank Limited amounted to Rs. 50.00 Lakh with Charge ID 100769359 was registered on 29 May 2023.
Appointed
Nagireddy Sanapalli was appointed as Director.
Appointed
Sanapalli Subbareddy was appointed as Director.
Appointed
Swapna Mukkara was appointed as Director.
Incorporation
07 Sep 2020
Ikem Pharma Private Limited was registered on 07 Sep 2020 with Roc Hyderabad & aged 6 years 1 month as per MCA records.
Frequently asked questions
Ikem Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 07 September 2020 (6+ years old) and is registered under CIN U24290TG2020PTC143617.
Ikem Pharma has 3 current directors:
- Nagireddy Sanapalli - Director
- Sanapalli Subbareddy - Director
- Swapna Mukkara - Director
The latest financial statements of Ikem Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Ikem Pharma is 36AAFCI7909A1ZQ, registered in Telangana.
The CIN (Corporate Identification Number) of Ikem Pharma is U24290TG2020PTC143617. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ikem Pharma was incorporated on 07 September 2020, making it 6+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Ikem Pharma by revenue are Vikram Laboratories Private Limited, Vivifi Life Sciences Private Limited, Good Kare Medico Private Limited, Daiwik Pharmasphere Private Limited, Colinz Laboratories Ltd and 1 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Nagireddy Sanapalli was appointed as Director on 07 Sep 2020. Sanapalli Subbareddy was appointed as Director on 07 Sep 2020. Swapna Mukkara was appointed as Director on 07 Sep 2020.
Yes, Ikem Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-09-0015667).
The registered office of Ikem Pharma is at 5 – 5 – 35331 Ncs Complex, 2nd Floor Prasanthi Nagar, Hyderabad, Telangana, India – 500072.
Ikem Pharma operates in the pharma industry, in the drug formulation and development segment.